Accuray Incorporated filings document financial results, Regulation FD presentations, governance changes, and material agreements for a radiation therapy systems company. Recent 8-K reports cover quarterly operating results, withdrawal of financial guidance, investor presentation materials, executive appointments and departures, consulting and separation arrangements, and equity-based compensation matters.
The filing record also includes formal disclosure controls and reporting-status matters, including a Form 12b-25 late 10-Q notification and non-reliance disclosures related to remaining performance obligation, or RPO, presentation in revenue footnotes. These filings connect Accuray's public-company reporting to revenue disclosure methodology, audit committee determinations, executive compensation terms, and corporate governance events.
Accuray Incorporated stockholders voted on three proposals at the 2026 Annual Meeting. Richard A. Meier was elected as a Class II director, with 37,636,958 votes for and 1,315,279 against; he will serve until the 2029 Annual Meeting or until a successor is duly elected or appointed. The advisory compensation proposal received 33,332,520 votes for and 5,793,203 against. Stockholders ratified Grant Thornton LLP as the Company's independent registered public accounting firm, with 70,844,250 votes for and 632,610 against. The vote totals are unadjusted for the 1-for-40 reverse stock split effective November 9, 2026; the October 8, 2026 record date preceded the split.
Accuray Inc. (ARAY) director Joseph E. Whitters had 1,415 restricted stock units vest in full on November 13, 2026, and acquired 1,415 shares of common stock. His reported common-stock holdings after the transaction were 18,106 shares. The holdings reflect Accuray’s 1-for-40 reverse split on November 9, 2026. No Rule 10b5-1 plan is reported.
Mika Nishimura, a director of Accuray Inc. (ARAY), reported the vesting of 1,415 restricted stock units on November 13, 2026, and the acquisition of 1,415 common shares. Her reported direct common-stock holdings afterward were 6,731 shares. The units vested 100% on that date; her reported common-stock holdings reflect the 1-for-40 split on November 9, 2026.
Accuray Inc. director Steven F. Mayer reported the vesting of 1,415 Restricted Stock Units on November 13, 2026, converting into 1,415 shares of common stock. Each RSU represents a contingent right to one common share. Mayer’s reported direct common-stock holdings after the transaction were 40,055 shares, adjusted to reflect Accuray’s 1-for-40 stock split on November 9, 2026.
Accuray Inc. director Chan Galbato reported that 1,415 restricted stock units vested on November 13, 2026, converting into 1,415 shares of common stock. After the transaction, Galbato directly held 2,665 common shares. The transaction was not reported under a Rule 10b5-1 plan; the share amounts reflect the 1-for-40 reverse split effective November 9, 2026.
Accuray Inc. director James M. Hindman had 1,415 restricted stock units vest and convert into 1,415 shares of common stock on November 13, 2026. His reported direct common-stock holdings after the transaction were 8,785 shares. The reported beneficially owned share counts were adjusted for the 1-for-40 stock split on November 9, 2026.
Accuray Inc. reported transactions by TCW Group Inc., a ten-percent owner, through affiliated holders. On November 13, 2026, TCW Rescue Financing Fund II LP, West Virginia Direct Lending LLC and TCW WV Financing LLC canceled warrants covering 350,197 common shares for no separate consideration. TCW Rescue Financing Fund II LP and TCW WV Financing LLC also purchased 30,959 Series A Convertible Preferred Stock shares at $1,000 per share.
The preferred stock has an initial conversion price of $20 per common share, subject to adjustment. The purchase was paid through a $10,625,000 cash investment funded July 29, 2026, and cancellation of $20,333,333.31 in indebtedness. After the warrant cancellations, TCW owns warrants covering 337,998 common shares at $0.01 per share, subject to a 19.9% beneficial-ownership limit. Accuray effected a 1-for-40 reverse stock split on November 9, 2026; reported share counts reflect the split.
Accuray Inc. issued 30,959 shares of Series A Preferred Stock to TCW Rescue Financing and TCW WV Financing on November 13, 2026, at $1,000 per share. The consideration included a $10,625,000 cash investment funded July 29, 2026, and cancellation of $20,333,333.31 in indebtedness. The preferred stock initially converts at $20 per common share. The TCW Business Unit reports shared voting and dispositive power over 1,547,950 common shares issuable upon conversion, approximately 34.0% on the stated basis.
The preferred stock accrues an 8% annual dividend, compounded quarterly if unpaid; the board may elect to pay it in cash or add it to stated value. At closing, warrants exercisable for an aggregate of 350,197 common shares were cancelled. Separate outstanding penny warrants exercisable for 337,998 shares cannot be exercised to the extent ownership would exceed 19.9%. TCW Asset Management Company LLC may designate up to two directors, with specified committee representation and consent rights.
Accuray Incorporated completed a financing transaction with TCW and certain existing investors, issuing 55,000 shares of Series A convertible preferred stock for an aggregate purchase price of $55.0 million, or $1,000 per share. The purchase price comprised $15.0 million in cash and conversion of $40.0 million of existing indebtedness. The shares were issued November 13, 2026, and certain financial covenants were waived through December 31, 2027.
The Series A preferred stock ranks senior to common stock for dividends and distributions on liquidation. It carries an 8% annual dividend on stated value, compounding quarterly when unpaid; the board may elect to pay dividends in cash or add them to stated value. Holders may convert at the initial rate of 50 common shares per $1,000 of stated value, equivalent to an initial $20.00 conversion price, subject to adjustments including for stock splits.
The 1-for-40 reverse split took effect November 9, 2026. Authorized common shares were reduced from 400,000,000 to 10,000,000 after an increase to 400,000,000. The transaction also canceled warrants that previously entitled holders to purchase approximately 27.6 million common shares before the split.
Accuray Incorporated reported revenue of $86.523 million for the three months ended September 30, 2026, versus $93.942 million a year earlier. Net income was $10.134 million versus a $21.678 million loss; the quarter included a $59.563 million gain on extinguishment of debt and a $35.392 million goodwill impairment. Loss from operations was $36.502 million versus $11.313 million.
Accuray agreed to sell 55,000 shares of Series A Convertible Preferred Stock for $55.0 million: $15.0 million cash was funded at signing and $40.0 million of existing debt is to be converted. Stockholders approved the proposals and reverse stock split on October 6, 2026, but closing remains subject to the split’s implementation and effectiveness and other conditions. Total debt carrying value was $101.672 million at September 30, 2026, versus $147.870 million at June 30, 2026.
Operating cash flow was $3.812 million used, versus $12.180 million provided a year earlier. Accuray expects supply-chain and logistics costs to continue affecting gross margins, net income and operating cash flow through at least fiscal 2027, while stating it expects sufficient resources to fund operations for at least 12 months.